2017
DOI: 10.1016/bs.ai.2017.06.003
|View full text |Cite
|
Sign up to set email alerts
|

β2-Adrenoceptor Function in Asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
18
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 20 publications
(18 citation statements)
references
References 127 publications
(127 reference statements)
0
18
0
Order By: Relevance
“…Although a different agonist (isoproterenol) was used in PCLS, both albuterol and isoproterenol were shown to have a similar bronchodilatory profile in patients [20]. Our study shows that in addition to tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-13 or IL-5, both TGF-β1 or FGF-2 can also drive β 2 -AR dysfunction in human ASM cells (reviewed in [21]). We also made the novel finding that ASM cells from severe asthmatics displayed a constitutive tyrosine phosphorylation of β 2 -ARs and blunted response to albuterol in the collagen gel assays.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…Although a different agonist (isoproterenol) was used in PCLS, both albuterol and isoproterenol were shown to have a similar bronchodilatory profile in patients [20]. Our study shows that in addition to tumour necrosis factor (TNF)-α, interleukin (IL)-1β, IL-13 or IL-5, both TGF-β1 or FGF-2 can also drive β 2 -AR dysfunction in human ASM cells (reviewed in [21]). We also made the novel finding that ASM cells from severe asthmatics displayed a constitutive tyrosine phosphorylation of β 2 -ARs and blunted response to albuterol in the collagen gel assays.…”
Section: Discussionmentioning
confidence: 90%
“…Our study shows that β 2 ‐AR dysfunction in ASM in asthma could result from the transient (induced by growth factors) or permanent (unknown mechanisms) phosphorylation of the receptor at both Tyr 141 and Tyr 350 residues. We propose that targeting the mechanisms leading to abnormal β 2 ‐AR phosphorylation have the potential to enhance β2‐agonist activity in patients with asthma, and perhaps reduce the unwanted adverse effects sometimes evident with their chronic use .…”
Section: Discussionmentioning
confidence: 99%
“…It is notable that carvedilol has been shown to promote inhibition of platelet function in several trials (Petrikova et al, 2005;Ilardi et al, 2018), and the present studies suggest a potential mechanism through which this may occur. ADRs are widely expressed on virtually every cell type and known to play important roles in myocardial and vascular function, as well as regulation of body homeostasis in both health and pathologic states (Amrani and Bradding, 2017;Hein and Kobilka, 1997;Lefkowitz et al, 2000;Rockman et al, 2002). Activation of the adrenergic system also has a profound effect on metabolism, and prolonged activation can lead to insulin resistance, alterations in glucose and fatty acid metabolism, and mitochondrial dysfunction (Ciccarelli et al, 2013;Fu et al, 2017).…”
Section: Discussionmentioning
confidence: 99%
“…β‐Adrenergic receptors are GPCR transmembrane protein receptors that include β2‐adrenoreceptors (ARDB2), primarily expressed in the airway smooth muscle 77 and on a variety of immune cell types involved in allergic responses such as Th2, ILC2, and eosinophils 78 (Fig. 3).…”
Section: Neuropeptides As Immunoregulatorsmentioning
confidence: 99%